Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Tislelizumab can cause cutaneous lupus erythematosus.

A woman developed lupus after taking hydroxyurea for two years.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

ADEM is a sudden brain disorder often following infection or vaccination, diagnosed by ruling out other conditions.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

BST2 protein and certain T cells increase in early alopecia areata.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Diagnosing both systemic lupus and hemoglobinopathy is challenging due to overlapping symptoms.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Denosumab treatment for osteoporosis can cause hair loss.

TPO antibodies can help identify hypothyroid patients who still have symptoms despite normal TSH levels.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Dupilumab can both heal and cause hair loss.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.